Keryx Biopharmaceuticals Has Returned 37.7% Since SmarTrend Recommendation (KERX)

SmarTrend identified an Uptrend for Keryx Biopharmaceuticals (NASDAQ:KERX) on March 2nd, 2016 at $4.49. In approximately 4 months, Keryx Biopharmaceuticals has returned 37.73% as of today's recent price of...